WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS
-
The Enzyme Bottleneck: Why Conventional Lake Management Is Failing — And What The Science Says About Genuine Bio-Dredging
For decades, the dominant framework for assessing and managing lake health has been built around surface water measurements: chlorophyll-a, total phosphorus, water clarity, and the composite Trophic State Index derived from them. These metrics are familiar, standardised, and widely accepted. They are also, according to a growing body of peer-reviewed literature, measuring the wrong part of the lake.
-
Ozone Off-Gas: What It Reveals About System Efficiency, Safety, and Design
Learn how ozone off-gas impacts system efficiency, safety, and performance, and why monitoring and management are critical for optimized water treatment operations.
-
UK Reservoirs, Water Shortages, And Legionella Risks
Is there a clear link between a less plentiful water supply and an increase in Legionella in our domestic water systems?
-
The Devastating Legacy Of Algaecides: Why The Quick Fix Is Failing Our Lakes As warmer months approach, water management professionals must confront the compounding consequences of biocidal algae treatments.
-
What Is The Future Of Source Water Protection? Water utility managers and municipal leaders have long struggled amid the convergence of several threats to public water supplies. During a recent Water Online Live event, I sat with a panel of industry experts to examine the transition from reactive crisis management to a proactive, adaptive resilience framework.
-
Drinking Water Contaminated With 'Forever Chemicals' During Pregnancy Linked To An Increased Risk Of Childhood Asthma
While most of us are routinely exposed to low levels of PFAS, some communities are exposed to far higher levels from nearby pollution sources. A new study shows that in one of these at-risk communities, children were more likely to develop asthma if their mothers were exposed to very high PFAS levels during pregnancy.
-
The Pragmatic Shift In Source Water Protection: Moving From Symptom Management To Root-Cause Accountability A shift in how we approach source water protection is long overdue. Currently, we are trapped in a cycle of escalating costs, forced to treat symptoms like algae and invasive weeds expediently with chemicals while the underlying risk in the reservoir compounds. True risk management requires breaking this cycle.
-
The AWWA Said $2.4 Trillion. It Missed The Compound Interest. Einstein once said of compound interest, "He who understands it, earns it. He who doesn't, pays it." The same logic of compounding applies to the organic sediment accumulating on the floor of your drinking water reservoir. The longer you wait to address it, the more exponentially expensive it becomes to fix.
-
Designing Resilient PFAS Treatment Strategies For Water Agencies Water agencies across the U.S. are facing a rapidly evolving regulatory landscape for per- and polyfluoroalkyl substances (PFAS) that poses a conundrum: Should they take a cautious or aggressive approach to treating PFAS contamination in their water system?
-
The Future Of In Situ Chemical Oxidation For Targeted Solvent Destruction
The U.S. EPA’s 2026 trichloroethylene (TCE) compliance deadlines are now forcing a concrete shift toward source-zone destruction. In situ chemical oxidation (ISCO), sequenced with enhanced bioremediation, is proving to be the most credible path to groundwater contaminant rebound mitigation.
VIEWS ON THE LATEST REGS
-
Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
-
With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
-
A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.
-
Assessing what lies ahead in the 10-year race to go lead-free, otherwise known as the Lead and Copper Rule Improvements (LCRI).
MORE WATER INDUSTRY FEATURES
-
For water treatment professionals prioritizing precision and efficiency, hollow-fiber microfiltration membranes are revolutionizing the way industries and municipalities treat water.
-
In vivo CAR-T scales patient access and cuts timelines but turns biological hurdles into complex manufacturing demands. Precise assays and tight raw material controls are vital for regulatory success.
-
Nitrosamines are a serious risk in drug products, driven by the presence of secondary amines, conducive conditions, and nitrosating agents. Understanding these factors is key to risk mitigation and patient safety.
-
Beaverton Water Division’s transition to Kamstrup AMI and acoustic leak detection is modernizing meter reading, reducing infrastructure costs, improving leak identification, and streamlining operations as deployment progresses.
-
Critical water tunnels require efficient structural renewal to meet strict shutdown schedules. Certified geopolymer mortar provides a cost-effective, high-strength solution that eliminates groundwater infiltration and improves water quality while ensuring a 70-year service life for essential aqueduct systems.
-
Breakthrough designation can unlock faster paths for rare disease therapies. Learn how smart timing, compelling evidence, and early regulatory alignment can turn promising science into accelerated patient impact.
-
Ozone is a vital pre-treatment for PFAS mitigation. It oxidizes precursors and co-contaminants, significantly extending the service life of downstream GAC and membrane systems.
-
mAb aggregation can arise from molecular properties, process conditions, and equipment‑driven stress. Learn where aggregation risk increases across downstream processing and formulation.
-
Engineers and project managers must take a complete cradle-to-grave approach when considering which technologies to implement as well as which vendors to partner with for their PFAS solution.
-
Read about how mixers help prevent stratification, maintain consistent disinfectant distribution, and reduce sediment buildup, thereby mitigating public health risks associated with water storage.
-
Explore how PFAS in medical devices pose environmental and health concerns, prompting regulatory scrutiny.
-
Poor solubility of active pharmaceutical ingredients can hinder drug effectiveness. Learn how innovative formulation strategies enhance solubility and bioavailability to improve therapeutic outcomes for challenging drug candidates.
-
Calgon Carbon’s Dr. Angela Rodriguez shares insights on PFAS treatment, regulatory readiness, sustainability, and how innovative carbon technologies help utilities balance compliance, cost control, and environmental goals.
-
Color consistency improves surgical visibility, differentiation, and workflow efficiency, requiring medical textiles that deliver strength, compliance, and reliable quality in every color.
-
Improve efficiency and water quality with demand-based flushing. The integration of sensors and smart networks allows utilities to remotely monitor and optimize flushing cycles.
-
Trenchless geopolymer rehabilitation offers a sustainable solution for culvert repair in sensitive ecosystems. Its rapid-curing, low-toxicity properties allow for quick service reinstatement, preserving hydraulic capacity and protecting local water quality and aquatic life without the need for disruptive excavation.
-
Antibody aggregation remains a critical downstream challenge, particularly for complex modalities. Explore why aggregates form, why they matter, and how chromatographic strategies can help reduce risk.
-
AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.